BIO Endorses Nomination of Von Eschenbach to Head FDA
Posted on: Tuesday, 1 August 2006, 12:01 CDT
WASHINGTON, Aug. 1 /PRNewswire/ -- Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), released a statement today encouraging the U.S. Senate to swiftly confirm Dr. Andrew von Eschenbach as commissioner of the Food and Drug Administration (FDA).
"Dr. Andrew von Eschenbach is an outstanding choice to serve as commissioner of the FDA. He will provide strong, certain leadership to this critical agency that protects our nation's public health.
"Dr. von Eschenbach's experience as a cancer surgeon and his leadership as director of the National Cancer Institute afford him unique insights into the critical need to advance new treatments for patients with life-threatening illnesses. As a teacher and academician, he appreciates the importance of education and research in achieving scientific breakthroughs.
"To provide safe and effective therapies for patients, and healthful foods for consumers, the country needs a confirmed FDA commissioner to ensure this agency is credible, predictable, and effective in protecting the public health.
"I applaud President George W. Bush for his selection of Dr. von Eschenbach, and I urge the Senate to move swiftly in the confirmation process."
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.
Biotechnology Industry Organization
CONTACT: Kim Coghill of Biotechnology Industry Organization,+1-202-962-9232
Web site: http://www.bio.org/
Source: PRNewswire
Related Articles
- FDA Commissioner Andrew Von Eschenbach, MD, to Speak at February 29 National Press Club Luncheon
- RegeneRx to Present at Biotechnology Industry Organization's 2007 Business Forum
- Statement By Mike Leavitt Secretary of Health and Human Services Regarding Senate HELP Committee Action on Dr. Andrew Von Eschenbach To Be New FDA Commissioner
- The Cancer Cure Coalition Supports the Nomination of Dr. Andrew Von Eschenbach As Commissioner of the U.S. FDA and Calls for the Approval of Advexin, a New Gene Therapy Treatment for Cancer
- Acting FDA Commissioner to Present Keynote Address at BIO Mid-America VentureForum 2006
- Bush picks von Eschenbach as FDA chief
- Bush picks von Eschenbach as FDA chief: W.House
- Bush seen picking von Eschenbach as FDA chief
- Bush expected to pick von Eschenbach as FDA chief
 |
 |
User Comments (0)
RSS Feeds